Search results
Author(s):
Alexander G Truesdell
,
Jaime A Hernandez-Montfort
,
Varinder Kaur Randhawa
Added:
2 years ago
In this in-depth discussion lead by Dr Alexander Truesdell (Virginia Heart/Inova Heart & Vascular Institute, US), contributors of Cardiogenic Shock Special Focus Collection, Dr Varinder K Randhawa (Cleveland Clinic, US) and Dr Jaime Hernandez-Montfort (Cleveland Clinic Florida, US) discuss the most prevalent questions on hemodynamic-based assessment and management of cardiogenic shock:
What is…
View more
Author(s):
Alexander G Truesdell
Added:
2 years ago
Author(s):
Alastair G Proudfoot
,
Alexander G Truesdell
Added:
2 years ago
Dr Alastair Proudfoot (Barts Heart Centre, UK) outlines the process requirements for care of the cardiogenic shock patients and where shock teams and centres fit into that underpinned by the latest available data. Dr Alexander Truesdell, Guest Editor of USC asks Dr Proudfoot about why we need shock teams. They discuss the challenges of treating patients with cardiogenic shock. They talk about…
View more
Author(s):
Shahana Uddin
,
Rathai Anandanadesan
,
Richard Trimlett
,
et al
Added:
1 year ago
Author(s):
Jaime A Hernandez-Montfort
,
Diana Miranda
,
Varinder Kaur Randhawa
,
et al
Added:
2 years ago
Author(s):
Andrea Elliott
,
Garima Dahyia
,
Rajat Kalra
,
et al
Added:
2 years ago
Author(s):
Sascha Ott
,
Laura Leser
,
Pia Lanmüller
,
et al
Added:
2 years ago
Author(s):
Alex F Warren
,
Carolyn Rosner
,
Raghav Gattani
,
et al
Added:
2 years ago
Author(s):
Biswajit Kar
,
Reynolds M Delgado III
Added:
3 years ago
Cardiogenic shock (CGS) results in inadequate end organ perfusion and is associated with high mortality. For patients presenting with CGS following myocardial infarction (MI), reported rates of mortality range between 55% and 80% despite aggressive pharmacological therapy and use of the intra-aortic balloon pump (IABP). Patients with CGS due to ventricular septal defect (VSD) or ventricular…
View more
Author(s):
Biswajit Kar
,
Reynolds M Delgado III
Added:
3 years ago
Cardiogenic shock (CGS) results in inadequate end organ perfusion and is associated with high mortality. For patients presenting with CGS following myocardial infarction (MI), reported rates of mortality range between 55% and 80% despite aggressive pharmacological therapy and use of the intra-aortic balloon pump (IABP). Patients with CGS due to ventricular septal defect (VSD) or ventricular…
View more